Biofrontera Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for BFRI, updated each market day.
BFRI AI Sentiment
AI sees no strong directional signal for Biofrontera Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Biofrontera Inc. Common Stock
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Sector
Exchange
Market Cap
$12,114,255
Cap Tier
Employees
94
Headquarters
WOBURN, MA
Listed Since
Oct. 29, 2021
Website
BFRI Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BFRI Volatility
Biofrontera Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
